Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherRevenue - OtherShares Issued
Ratios

Nuvation Bio (NUVB-WT) R&D In Process (2024)

Nuvation Bio (NUVB-WT) has disclosed R&D In Process for 1 consecutive years, with $425.1 million as the latest value for Q2 2024.

  • Quarterly R&D In Process changed N/A to $425.1 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $425.1 million through Jun 2025, changed 0.0% year-over-year, with the annual reading at $425.1 million for FY2024, N/A changed from the prior year.
  • R&D In Process for Q2 2024 was $425.1 million at Nuvation Bio.
  • The five-year high for R&D In Process was $425.1 million in Q2 2024, with the low at $425.1 million in Q2 2024.